---
title: "Key facts: Abbott Q1 diagnostics -7.4%; guidance cut; Exact Sciences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283048446.md"
description: "Abbott (ABT) Q1 sales fell; rapid and molecular diagnostics down 7.4% to $812M, weaker nutrition and diabetes device sales, heart devices lost share to Edwards. Shares fell ~4–6% after outlook cut.1Abbott Laboratories (ABT) Q1 CY2026 adjusted EPS $1.15, in line with estimates. Full-year adjusted EPS guidance cut to $5.48 midpoint, a 3.4% reduction from prior outlook.2Abbott (ABT) says Exact Sciences deal boosted its oncology diagnostics and helped growth; Medical Devices and Established Pharmaceuticals segments showed solid performance.3"
datetime: "2026-04-16T20:07:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283048446.md)
  - [en](https://longbridge.com/en/news/283048446.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283048446.md)
---

# Key facts: Abbott Q1 diagnostics -7.4%; guidance cut; Exact Sciences

-   Abbott (ABT) Q1 sales fell; rapid and molecular diagnostics down 7.4% to $812M, weaker nutrition and diabetes device sales, heart devices lost share to Edwards. Shares fell ~4–6% after outlook cut.1
-   Abbott Laboratories (ABT) Q1 CY2026 adjusted EPS $1.15, in line with estimates. Full-year adjusted EPS guidance cut to $5.48 midpoint, a 3.4% reduction from prior outlook.2
-   Abbott (ABT) says Exact Sciences deal boosted its oncology diagnostics and helped growth; Medical Devices and Established Pharmaceuticals segments showed solid performance.3

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [EXAS.US](https://longbridge.com/en/quote/EXAS.US.md)
- [EW.US](https://longbridge.com/en/quote/EW.US.md)

## Related News & Research

- [Abbott (ABT) Stock May Be 32% Undervalued As Legal Overhang Fades](https://longbridge.com/en/news/293449087.md)
- [23:20 ETPRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation Under Investigation for Data Breach of Patient Records](https://longbridge.com/en/news/293695963.md)
- [Key facts: Abbott completes TECTONIC IVL; closes Exact; raises guidance](https://longbridge.com/en/news/292999283.md)
- [Abbott Laboratories (NYSE:ABT) Receives "Buy" Rating from TD Cowen](https://longbridge.com/en/news/293049557.md)
- [Ironwood Investment Counsel LLC Purchases Shares of 11,963 Abbott Laboratories $ABT](https://longbridge.com/en/news/293194413.md)